IL6 and COVID-19: In a special cohort of 287 COVID-19 patients, 20.2% of patients were reported to have thyrotoxicosis, having TSH levels below the normal range, and multivariate analysis revealed an opposite connection between TSH values in serum and cytokine interleukin-6 (IL-6 levels) [147].